Showing results (291-300 of 407) with videos related to
Sort By:
Pageof 41
The Journal of Rheumatology|October 15, 2025
Predicting treatment outcomes in patients with psoriatic arthritis or axial spondyloarthritis: An artificial intelligence-driven approachAsmir Vodenčarević, Jan Brandt-Jürgens, Sara Bär, et al.Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 21, 2021
[Treatment of psoriasis with secukinumab : Practical guidance]Andreas Körber, Matthias Augustin, Frank Behrens, et al.Arthritis Research & Therapy|July 8, 2021
Implementing an automated monitoring process in a digital, longitudinal observational cohort studyLisa Lindner, Anja Weiß, Andreas Reich, et al.Clinical and Experimental Rheumatology|January 9, 2023
Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational studyFrank Behrens, Gerd-Rudiger Burmester, Michael W Hofmann, et al.Clinical and Experimental Rheumatology|May 18, 2021
Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily careFrank Behrens, Gerd-Rüdiger Burmester, Martin Feuchtenberger, et al.Annals of the Rheumatic Diseases|December 16, 2021
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trialLars Erik Kristensen, Mauro Keiserman, Kim Papp, et al.The New England Journal of Medicine|October 19, 2017
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF InhibitorsDafna Gladman, William Rigby, Valderilio F Azevedo, et al.Joint Bone Spine|March 27, 2021
A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to actionJordi Gratacós, Frank Behrens, Laura C Coates, et al.Modern Rheumatology|August 3, 2022
Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3)Tatsuya Atsumi, Yoshiya Tanaka, Tsukasa Matsubara, et al.Frontiers in Immunology|June 27, 2022
Endothelin B Receptor Immunodynamics in Pulmonary Arterial HypertensionChristoph Tabeling, Carla R González Calera, Jasmin Lienau, et al.Pageof 41